Is (18)F-FDG PET/CT an accurate tool for identifying metastases of lobular breast cancer?

Acta Oncol. 2016;55(2):244-7. doi: 10.3109/0284186X.2015.1054952. Epub 2015 Jun 24.

Authors

Marina Orevi¹, Nanette Freedman¹, Esther Tahover², Beatrice Uziely², Roland Chisin¹, Tamar Peretz², Martine Klein¹

Affiliations

¹ a Department of Medical Biophysics and Nuclear Medicine , Hadassah Hebrew University Medical Center , Jerusalem , Israel.
² b Department of Oncology , Hadassah Hebrew University Medical Center , Jerusalem , Israel.

PMID: 26106853
DOI: 10.3109/0284186X.2015.1054952

No abstract available

Publication types

Clinical Trial
Letter

MeSH terms

Aged
Breast Neoplasms / mortality
Breast Neoplasms / pathology*
Carcinoma, Ductal, Breast / mortality
Carcinoma, Ductal, Breast / pathology
Carcinoma, Intraductal, Noninfiltrating / mortality
Carcinoma, Intraductal, Noninfiltrating / pathology
Carcinoma, Lobular / mortality
Carcinoma, Lobular / pathology*
Female
Fluorodeoxyglucose F18
Humans
Kaplan-Meier Estimate
Lymphatic Metastasis / pathology
Middle Aged
Positron-Emission Tomography / methods*
Radiopharmaceuticals
Tomography, X-Ray Computed / methods*

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18